Online inquiry

IVTScrip™ mRNA-Human APOBEC3G, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28523MR)

This product GTTS-WK28523MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the APOBEC3G protein. This product can be used in Exhausted CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001349436.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 60489
UniProt ID Q9HC16
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APOBEC3G, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28523MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK1930MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK8554MR IVTScrip™ mRNA-Human ACSS1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACSS1
GTTS-WK9702MR IVTScrip™ mRNA-Human ACAA2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACAA2
GTTS-WK9022MR IVTScrip™ mRNA-Human AASDHPPT, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AASDHPPT
GTTS-WK21818MR IVTScrip™ mRNA-Human ASMTL, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASMTL
GTTS-WK9256MR IVTScrip™ mRNA-Human ADK, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADK
GTTS-WK8855MR IVTScrip™ mRNA-Human ACSS2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACSS2
GTTS-WK23320MR IVTScrip™ mRNA-Human ASNS, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASNS
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →